001328.SZ
Dencare (Chongqing) Oral Care Co., Ltd.
SZSE · C 制造业 · CN
CNY 32.39
−1.91%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.8B | 1.7B | 1.6B | 1.4B | 1.3B |
| Cost of Revenue | 863.1M | 819.7M | 789.8M | 769.0M | 781.4M |
| Gross Profit | 917.7M | 896.1M | 770.2M | 606.8M | 531.9M |
| Operating Expenses | |||||
| R&D Expense | 53.9M | 52.2M | 48.1M | 42.7M | 40.1M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 74.0M | 73.4M | 73.7M | 66.9M | 54.3M |
| Selling & Marketing Expense | 604.0M | 592.8M | 498.6M | 386.3M | 315.3M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 735.1M | 721.3M | 620.7M | 488.1M | 408.8M |
| Cost and Expenses | 1.6B | 1.5B | 1.4B | 1.3B | 1.2B |
| Operating Income (EBIT) | 214.8M | 205.5M | 187.2M | 147.5M | 144.8M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 217.8M | 208.4M | 186.9M | 160.8M | 145.8M |
| Income Tax Expense | 28.1M | 27.4M | 25.7M | 19.5M | 11.1M |
| Bottom Line | |||||
| Net Income | 189.7M | 181.1M | 161.2M | 141.3M | 134.6M |
| Earnings from Cont. Ops | 189.7M | 181.1M | 161.2M | 141.3M | 134.6M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 189.7M | 181.1M | 161.2M | 141.3M | 134.6M |
| Per Share | |||||
| Basic EPS | CN¥1.10 | CN¥1.05 | CN¥0.94 | CN¥0.88 | CN¥1.04 |
| Diluted EPS | CN¥1.10 | CN¥1.05 | CN¥0.94 | CN¥0.88 | CN¥1.04 |
| Revenue Per Share | CN¥10.32 | CN¥9.95 | CN¥9.10 | CN¥8.57 | CN¥10.15 |
| Shares | |||||
| Basic Shares Outstanding | 172.6M | 172.5M | 171.5M | 160.6M | 129.4M |
| Diluted Shares Outstanding | 172.6M | 172.5M | 171.5M | 160.6M | 129.4M |
| Profitability Metrics | |||||
| EBITDA | — | 227.3M | 208.2M | 160.0M | 155.1M |
| D&A | — | 21.8M | 21.1M | 12.5M | 10.2M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026